1340-Sensitize Liver Cancer for Immunotherapy
This research identifies the enzyme SOAT1 as a primary driver of immune evasion and cancer recurrence in hepatocellular carcinoma (HCC). By analyzing human patient samples and mouse models, the authors demonstrate that SOAT1 supports tumor resilience by converting free cholesterol into esters, which maintains the metabolic and antioxidant capacity of cancer cells. Inhibiting this enzyme leads to cholesterol accumulation in the endoplasmic reticulum, disrupting lipid synthesis and leaving tumors vulnerable to lipid peroxidation. Consequently, targeting SOAT1 enhances the effectiveness of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.